Back to results
US 2008/0300646 A1Published application
Treatment of cardiomyopathy, heart failure and cardiac ischemia using stimulation induced secretion of glp-1
AssigneePacesetter, Inc.
InventorMartin Cholette
Life of this patent
Estimating the term…
Abstract
An exemplary method for treating heart failure includes diagnosing heart failure and calling for delivery of energy to the distal ileum to activate L cells using an implantable device where activation of L cells causes release of GLP-1 and where release of GLP-1 treats heart failure. Various other methods, devices, systems, etc., are also disclosed.
Claims16
A method for increasing cardiac output, the method comprising:
- detecting a need for increased cardiac output;
- and
- calling for delivery of energy to the distal ileum to activate L cells using an implantable device wherein activation of L cells causes release of GLP-1 and wherein release of GLP-1 increases cardiac output.
A method to increase cardiac output, the method comprising:
- detecting a need for increased cardiac output;
- and
- activating at least one member selected from a group consisting of vagal nerves, K cells and L cells by using an implantable device, wherein the activating induces, directly or indirectly, release of GLP-1 increases cardiac output.
An implantable cardiac device comprising:
- detection circuitry adapted to diagnose low cardiac output;
- and
- stimulation circuitry adapted to call, in response to the detection circuitry diagnosing the low cardiac output, for delivery of energy to the distal ileum to activate L cells wherein activation of L cells causes release of GLP-1 and wherein release of GLP-1 increases cardiac output.
Dependencies are inferred from the claim text.